IL33 and neoplasm: Notably, it was found that the intratumoral mycobiome can promote the production of IL-33 from cancer cells and subsequently enhance the recruitment and activation of Th2 cells and innate lymphoid cells in the microenvironment of pancreatic cancer, thus inhibiting the progression of the tumor (89).